Integra LifeSciences Corporation Amends and Restates $2.2 Billion Credit AgreementMay 3, 2018
S&C client Integra LifeSciences Holdings Corporation amended and restated its existing $2.2 billion credit agreement. The amendment and restatement revised the company’s existing credit agreement to provide additional flexibility to conduct acquisitions and dispositions, decrease the applicable interest rates and commitment fees, extend the maturity of its credit facilities and allocate a greater portion of its facility to its revolving credit facility. Bank of America, N.A. acted as administrative agent, and JPMorgan Chase Bank, N.A. and Wells Fargo Bank, N.A. acted as co-syndication agents.
Integra LifeSciences is a global leader in medical technology, offering innovative solutions, including leading regenerative technologies, in specialty surgical solutions, orthopedics and tissue technologies.
The S&C team was led by Ari Blaut, along with Moritz Raepple, Lindsey Chandler and Katherine Nemeth.